Joel Mermis M.D.
Adult program director
As the adult CF program director and TDC director, my focus at the University of Kansas Medical Center (KUMC) is on helping the CF community improve care delivery and advance therapeutics for people with CF. Since joining the TDN in 2012, the cystic fibrosis clinical research program at KUMC has rapidly grown. During this time, I have had the opportunity to be the principal investigator for various observational and therapeutic phase one, two, three clinical trials, and have participated in investigator-initiated CF research projects. I have particular interest in quality improvement and have published improvement efforts focused on PICC associated DVT and infection control.